Stem Point Capital LP Roivant Sciences Ltd. Transaction History
Stem Point Capital LP
- $499 Billion
- Q3 2025
A detailed history of Stem Point Capital LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Stem Point Capital LP holds 4,197,187 shares of ROIV stock, worth $85.2 Million. This represents 12.72% of its overall portfolio holdings.
Number of Shares
4,197,187
Previous 601,781
597.46%
Holding current value
$85.2 Million
Previous $6.78 Billion
836.34%
% of portfolio
12.72%
Previous 2.18%
Shares
8 transactions
Others Institutions Holding ROIV
# of Institutions
373Shares Held
436MCall Options Held
6.05MPut Options Held
2.52M-
Morgan Stanley New York, NY44.3MShares$899 Million0.04% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X040.3MShares$818 Million4.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA38.8MShares$787 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$718 Million0.01% of portfolio
-
Qvt Financial LP New York, NY29.4MShares$596 Million36.4% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14.3B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...